Erudio Healtherudio.com
Sponsor
University of Chicago trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by University of Chicago: COSINR. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 4 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (University of Chicago). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| COSINR NCT03223155 · University of Chicago | stage IV non-small cell lung cancer | Phase 1 | 235 | 21 | Standard | Oct 30, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NCT06291987 NCT06291987 · University of Chicago StandardView → | IDH1-mutated advanced-phase myeloproliferative neoplasms | Phase 1 | Standard | View | |||
| TARGET-HPV NCT05108870 · University of Chicago FocusedView → | locoregional HPV16+ oropharyngeal squamous cell carcinoma | Phase 1/Phase 2 | Focused | View | |||
| NCT03571321 NCT03571321 · University of Chicago FocusedView → | Not given | Phase 1 | Focused | View | |||
| C4-MOSART NCT03431948 · University of Chicago FocusedView → | Not given | Phase 1 | Focused | View | |||